长期偏头痛时使用肉毒毒素
Lejla Paracka1, Dirk Dressler2,3
1Movement Disorders Section, Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. paracka.lejla@mh-hannover.de.
Journal of neural transmission (Vienna, Austria : 1996)
|November 6, 2025
概括
毒素 (BoNT) 为慢性偏头痛 (CM) 提供了一个有前途的治疗方法,特别是当标准疗法失败时. 临床试验证实了BoNT的存在.
科学领域:
- 神经学 神经学
- 疼痛管理 疼痛管理
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性偏头痛 (CM) 是一种使人衰弱的疾病,每月影响15天以上.
- 标准治疗常常证明具有挑战性或引起不良影响.
- 毒素 (BoNT) 是一种新兴的CM治疗选择.
研究的目的:
- 审查治疗慢性偏头痛 (CM) 的肉毒素 (BoNT) 的疗效和安全性.
主要方法:
- 对CM的BoNT进行多项随机对照试验 (RCT) 的综述.
- 分析BoNT调节疼痛通路的机制.
- 对头痛频率和安全性的临床结果的评估.
主要成果:
- 在CM患者中,BoNT显著减少了头痛频率.
- 对CM的BoNT临床疗效和安全性得到了RCT的支持.
- 对于那些对标准治疗没有反应的患者来说,BoNT特别有益.
结论:
- 毒素 (BoNT) 是慢性偏头痛 (CM) 的有效和安全治疗方法.
- 对于耐火性CM病例,BoNT提供了一个有价值的治疗策略.
- 支持进一步了解BoNT在疼痛调节中的作用.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.1K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.1K
Skeletal Muscle Relaxants: Therapeutic Uses
869
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
869
Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
Cholinergic Antagonists: Therapeutic Uses
1.3K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.3K
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
4.4K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
4.4K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
869
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
869


